▲ Top longRank #1 of 50
VRTXVertex Pharmaceuticals Incorporated
99/100
- Quality
- 84th
- Cheap
- 56th
- Sector
- Health Care
Long: #2 of 100 on Richard Driehaus's long-minus-short score (0.535).
Loading the page…
“Buy high, sell higher: earnings surprises and momentum.”
Not affiliated with Richard Driehaus or Driehaus Capital Management. This bot is a computer model Pick100 built from Richard Driehaus's public statements and filings. Richard Driehaus did not create, review or endorse it, its picks are not Richard Driehaus's picks, and chatting with it is not talking to Richard Driehaus. Legal notice
01How the bot thinks
Every Nasdaq 100 company is ranked on what the playbook cares about. Its long score, for how well a company fits:
The closest fits to the checklist: fast earnings growth, up over the last month, strong six-month trend. Score near 100.
A separate short score hunts the worst fits: slow or falling earnings, down over the last month, weak six-month trend. Re-ranked every trading day, at the close. Loss-makers are allowed long.
How far a company sits from the checklist: slow or falling earnings, down over the last month, weak six-month trend.
02Model output
Long: #2 of 100 on Richard Driehaus's long-minus-short score (0.535).
Short: #1 of 50 shorts on Richard Driehaus's long-minus-short score (-0.64).
03The bot's own results
7 of 8 right
The side its portfolio held on each day's stock. The bot doesn't pick: it holds all 100.
04The full book
Equal weight: $1,000 a position. Cheap and Quality are percentiles within the Nasdaq 100; a dash means the figure is missing.
05Method and limits
The 100 Nasdaq 100 companies. Anything outside it can't be held.
Long score: Earnings growth 4, Last month 2, 6-month trend 2, Size 2, Revenue growth 1. Short score: Earnings growth 4, Last month 3, 6-month trend 1, Revenue growth 1. Each a weighted blend of the company's percentile on each measure; the 50 with the best long minus short go long.
Always 50 long and 50 short. No market or rate bets. Changes fill at the next close.
Some tickers are missing figures and sit mid-pack on that measure. This profile is a draft and has not been reviewed yet.
Modeled on Richard Driehaus's published approach. It is not Richard Driehaus, and its picks are not Richard Driehaus's. A free game on real closing prices, not investment advice.